SCM
GSK icon

Segantii Capital Management’s GSK GSK Stock Holding History

Segantii Capital Management’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-80,000
Closed -$4.27M – 87
2019
Q3 		$4.27M Buy
+80,000
New +$4.12M 0.58% 33

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Segantii Capital Management's GSK Position: Q4 2019 in Review

Segantii Capital Management sold out of GSK (GSK) in Q4 2019, closing a stake of 80,000 shares — an estimated $4.27M sold.

Segantii Capital Management first reported a position in GSK in Q3 2019 and held it in 1 quarter. The position peaked at $4.27M in Q3 2019. 894 funds tracked by Wall St. Rank hold GSK as of Q4 2019.

  • Segantii Capital Management reported no remaining GSK position as of Q4 2019 after selling out during the quarter.
  • Segantii Capital Management sold 80,000 GSK shares in Q4 2019, an estimated $4.27M.
  • Segantii Capital Management first reported a position in GSK in Q3 2019 and held it in 1 quarter.
  • Segantii Capital Management's GSK position peaked at $4.27M in Q3 2019.
  • 894 funds tracked by Wall St. Rank held GSK as of Q4 2019.

Based on Segantii Capital Management's 13F filing for Q4 2019, filed 30 Jan 2020.